(Q34215602)

31 July 2017

1 reference

title

Treatment of chemotherapy-induced alopecia (English)

1 reference

31 July 2017

1 reference

Caroline E Yeager

1

1 reference

31 July 2017

Elise A Olsen

series ordinal

2

1 reference

31 July 2017

publication date

1 July 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

24

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

432-442

1 reference

On the receiving end--patient perception of the side-effects of cancer chemotherapy.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Perception of chemotherapy side effects cancer versus noncancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Changing patient perceptions of the side effects of cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Knowledge, Expectations and Experiences of Patients receiving Chemotherapy for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Postmenopausal women with breast cancer: their experiences of the chemotherapy treatment period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Work problems after breast cancer: an exploratory qualitative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Living in it, living with it, and moving on: dimensions of meaning during chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: a willingness to pay study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Have men been overlooked? A comparison of young men and women's experiences of chemotherapy-induced alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Chemotherapy-Induced Alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Prevention of chemotherapy-induced hair loss by scalp cooling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Doxorubicin-induced hair loss and possible modification by scalp cooling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

The relationship between local scalp skin temperature and cutaneous perfusion during scalp cooling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Effects of temperature and doxorubicin exposure on keratinocyte damage in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Effectiveness of cold cap in the prevention of docetaxel-induced alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Alopecia and cytotoxic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

A randomized trial of minoxidil in chemotherapy-induced alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Protection against Chemotherapy-Induced Alopecia by Cyclosporin A in the Newborn Rat Animal Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Permanent chemotherapy-induced alopecia: case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Six cases of permanent alopecia after various conditioning regimens commonly used in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Permanent alopecia after busulfan chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

Prevention of chemotherapy-induced alopecia in rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

A New Strategy for Modulating Chemotherapy-Induced Alopecia, Using PTH/PTHrP Receptor Agonist and Antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

A new immunomodulating compound (AS-101) with potential therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01430.X

10.1111/J.1529-8019.2011.01430.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference